Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3-Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?
about
Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3-Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Comparative Efficacy and Toler ...... rable as an Initial Treatment?
@en
Comparative Efficacy and Toler ...... rable as an Initial Treatment?
@nl
type
label
Comparative Efficacy and Toler ...... rable as an Initial Treatment?
@en
Comparative Efficacy and Toler ...... rable as an Initial Treatment?
@nl
prefLabel
Comparative Efficacy and Toler ...... rable as an Initial Treatment?
@en
Comparative Efficacy and Toler ...... rable as an Initial Treatment?
@nl
P2093
P2860
P356
P1476
Comparative Efficacy and Toler ...... rable as an Initial Treatment?
@en
P2093
Akinori Nukui
Minoru Kobayashi
Takao Kamai
P2860
P356
10.1111/LUTS.12153
P577
2016-12-23T00:00:00Z